Form 4 for CL Colgate-Palmolive
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001225208-24-008719 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-12 | CL | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +3,630 | 8,801 | +70% | $0 |
| D | 2024-09-16 | 2024-09-13 | CL | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $105.73 | -762 | 8,039 | -9% | -$80.6K |
| D | 2024-09-16 | 2024-09-12 | CL | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +25.6K | 25.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | A | A | 3,630 | $0.00 | 8,801 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-13 | F | D | 762 | $105.73 | 8,039 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-09-12 | A | A | 25,563 | $0.00 | 25,563 | D | $106.34 · — to 2032-09-12 | 25,563 Common Stock | (F4) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 12, 2024 grant date. |